<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microangiopathic antiphospholipid-associated syndromes (MAPSs) are reported as encompassing several conditions mainly affecting the microvasculature of selected organs: the liver in <z:e sem="disease" ids="C0162739" disease_type="Disease or Syndrome" abbrv="HELLP">HELLP syndrome</z:e> (<z:mp ids='MP_0010163'>hemolysis</z:mp>, <z:hpo ids='HP_0002910'>elevated liver enzymes</z:hpo>, and low platelet); kidney, brain, and skin in <z:chebi fb="1" ids="18284">TTP</z:chebi> (thrombotic thrombocytopenic <z:hpo ids='HP_0000979'>purpura</z:hpo>) </plain></SENT>
<SENT sid="1" pm="."><plain>It is predominant in patients with catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>A recent report suggests that APS is not only a <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombotic disease</z:e> but also associated with microangiopathic features, and it can explain the greater prevalence of <z:e sem="disease" ids="C0162739" disease_type="Disease or Syndrome" abbrv="HELLP">HELLP syndrome</z:e> in these patients </plain></SENT>
<SENT sid="3" pm="."><plain>We here report a case of MAPS during pregnancy associated with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) in early second trimester </plain></SENT>
</text></document>